Zobrazeno 1 - 10
of 142
pro vyhledávání: '"D. Betticher"'
Autor:
M.P. Mathey, J. Bouquet de Jolinière, A. Major, B. Conrad, F. Khomsi, D. Betticher, M. Devouassoux, A. Feki
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Small cell carcinoma of the ovary is a very rare, highly undifferentiated, aggressive malignancy that affects young women and linked to a poor prognosis (especially women under 40 years of age). We present a 22 years old African woman
Autor:
C Taverna, M Bargetzi, D Betticher, J Gmür, M Gregor, U Hess, N Ketterer, E Lerch, T Matthes, U Mey, T Pabst, C Renner
Publikováno v:
Swiss Medical Weekly, Vol 140, Iss 3738 (2010)
The treatment of multiple myeloma has undergone significant changes in the recent past. The arrival of novel agents, especially thalidomide, bortezomib and lenalidomide, has expanded treatment options and patient outcomes are improving significantly.
Externí odkaz:
https://doaj.org/article/5720a28143ee47f8b2e120a562ef7699
Publikováno v:
Leuk Lymphoma
Vinorelbine chemotherapy with granulocyte colony stimulating factor (G CSF) stimulation is a widely applied non myelosuppressive mobilization regimen in Switzerland for myeloma patients but its neurotoxic potential limits its use in patients with bor
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D, Hayoz, D, Betticher
Publikováno v:
Revue medicale suisse. 10(425)
Publikováno v:
Revue medicale suisse. 10(425)
Thrombotic microangiopathy or "TMA" including thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) became a public health problem following the European outbreak of E. coli (O104:H4) gastroenteritis in 2011. A rapid diagnosis
Autor:
S, Zimmermann, D, Betticher
Publikováno v:
Revue medicale suisse. 10(425)
Multiple new cancer drugs have been marketed during the last decade, and among those many molecularly targeted agents. Their impact on clinical outcomes population-wide remains hard to measure. Are we merely seeing the development of expensive and to
Publikováno v:
Revue medicale suisse. 10(425)
Thanks to medical progress, the life expectancy of a majority of severely ill patients has greatly improved. The fact that these patients will live longer with their disease encourages new solutions to respond to the challenges of care continuity, co
Autor:
D. Betticher, Anis Feki, N. Ben Ali, L. Guillou, Henri-Marcel Hoogewoud, J. Bouquet de la Joliniere, A. Sutter, Jean-Bernard Dubuisson, Anis Fadhlaoui
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
Frontiers in Oncology
Frontiers in Oncology
Objective: In this article, we present two case reports. The first case was a malignant germ cell tumor of the right ovary in a 23 year old female and a case of a bilateral undifferentiated granulosa cell tumor in a 71 year old female. The aim of the